During a break in closing arguments in the murder trial of a former Minneapolis police officer accused of excessive force and killing George Floyd, Floyd's family members and attorneys reacted with pleas for justice. (Apirl 19)
During a break in closing arguments in the murder trial of a former Minneapolis police officer accused of excessive force and killing George Floyd, Floyd's family members and attorneys reacted with pleas for justice. (Apirl 19)
The 34-year-old father of three was sentenced to two years' jail and six strokes of the cane.
A teenager doing army recruitment training "went blank" before letting go of a ladder and falling metres into a flooded tunnel, a NSW inquest into his death has heard.Private Liam Wolf, 18, died two days after the fall, on April 21, 2019.
To many, mixing friends and family with business is a deal breaker. Sarah*, 19, a student, decided to take a chance and venture into a business with her friend turned business partner using money she borrowed from her parents.
Dane Haylett-Petty's playing future is in the balance after the Wallabies star suffered a major set-back in his recovery from ongoing concussion symptoms.The Melbourne Rebels captain made a comeback after six months out through Brisbane club rugby at the start of the month.
Married At First Sight's Alana Lister has finally confirmed what ended her relationship with Jason Engler.
Amazon says it prevented more than 10 billion fraudulent product listings from appearing in its online stores in 2020 and seized more than two million counterfeit products.The online giant's latest brand protection report said its verification processes also stopped more than six million attempts to create selling accounts because they were deemed suspicious.
Clashes broke out between Palestinians and Israeli police in East Jerusalem on Sunday.Protesters threw stones and lit fires as police officers on horseback used stun grenades to repel them.They are just the latest incidences of violence in the city, which has seen tensions escalate during the Muslim holy month of Ramadan.One of the issues fueling the anger is the planned eviction of Palestinian families from the Sheikh Jarrah neighborhood by Jewish settlers.The case was put on hold on Sunday for several weeks after Israel's Attorney General secured a deferment of the High Court hearing scheduled for Monday. A lower court had ruled in favor of Jewish settlers' claim to the land. Palestinian Nabil Kurd welcomed the delay to the case:"I'm very optimistic because of the court's decision, because the legal system is not able to reach a decision in this case. And the reason is because deep inside they know that this land is Arab Palestinian and the papers have been forged."But one Israeli who identified himself as Yaakov said it should go ahead:"I think it's a disgrace that after two weeks of brutal violence against Jews in the neighbourhood - unprovoked - that the court has decided to reward their violence, to reward their terrorism and to delay the ruling."Tensions are expected to remain high over the coming days despite growing international calls for calm.On Monday, Israel will mark Jerusalem Day - its annual celebration of the capture of East Jerusalem during the 1967 Middle East war.The status of the city is highly contested - Palestinians want East Jerusalem as the capital of a future state in the occupied West Bank and Gaza. Israel views all of the city as its capital, including the eastern part that it annexed in a move that has not won international recognition.
Witnesses have described chaotic scenes as bystanders attempted to restrain an alleged stabber.
Amazon (NASDAQ:AMZN) today released its 2020 Brand Protection Report which provides a comprehensive view of how it ensures customers shop from authentic products in its stores. Amazon makes significant investments in dedicated teams and industry-leading machine learning technology to proactively protect customers, brands and its selling partners from counterfeiters, and to hold them accountable if they attempt to sell fakes through Amazon. In 2020, Amazon invested more than $700 million and employed more than 10,000 people to protect its stores from fraud and abuse.
Sydney coach John Longmire wants the AFL to put its chainsaw back in the cupboard and consider the toll that soft-cap cuts are taking on staff at all 18 clubs.The league instructed each team to cut their football-department spending by approximately $3 million amid the financial damage created by the COIVD-19 pandemic.
Customer growth and expansion of sales & marketing teams following Indico Series B driving executive team additionsBOSTON, May 10, 2021 (GLOBE NEWSWIRE) -- Indico, a provider of intelligent process automation for the intake, understanding, and automation of document-based workflows, today announced new additions to the company’s executive leadership. Following the company’s Series B at the end of 2020, Indico has continued to add to its Fortune 500 customer roster as well as doubling headcount in the first quarter of 2021. Today Indico announced the following key additions to the executive leadership team: Mike Minelli, Senior Vice President Sales & Alliances Mike Minelli will be the driving force behind Indico’s growing footprint in the nascent AI-driven business workflow intelligent process automation (IPA) space. Prior to joining Indico, Mike was the SVP Enterprise/Global Strategic Accounts at Automation Anywhere, a Series B cloud-native, AI-powered RPA (Robotic Process Automation) SaaS startup, where he led a team that delivered to their monumental sales growth. Mike brings over 20 years of executive leadership experience with a focus on cloud-based and AI-driven SaaS products. During his career, he has brought four startups to acquisition and has worked at world class technology companies, such as Salesforce, Opsware and Netscape. Mike has expertise in defining product-market fit, building world-class sales teams, and creating strong partnerships. Mike Earley, Senior Vice President of Finance In his role, Mike Earley will assume the responsibility for leading accounting and finance, and will focus on strategic initiatives aimed at driving growth and increasing Indico's enterprise value. Mr. Earley brings with him an extensive background in corporate finance, strategic planning, investor relations, capital raising, treasury, and financial planning and analysis, along with demonstrated success in developing strategies to deliver revenue and EBITDA growth for private technology companies. He is an accomplished financial leader with more than 20 years of leadership experience and success working with both high-growth public and private companies. “Indico is excited to have these seasoned professionals join the team. It is a critical but exciting time in our history, where we have just recently had a major platform release, secured $22 million in Series B funding and have invested heavily in staff to help us accelerate our growth,” said Tom Wilde, Indico CEO. About IndicoIndico is the leading provider of Intelligent Process Automation (IPA) solutions. We help organizations turn process into profit by enabling them to automate manual, labor-intensive, document-based workflows. Our breakthrough in solving these challenges is an approach known as transfer learning, which allows users to train machine learning models with orders of magnitude less data than required by traditional rule-based techniques. With Indico, enterprises are now able to deploy AI to unstructured content challenges more effectively while eliminating many of the common barriers to adoption. For more information, visit https://indico.io/. Media Contact for IndicoKirsten EvansKirsten.firstname.lastname@example.org
(Bloomberg) -- Sony Group Corp. warned a group of analysts the PlayStation 5 will remain in short supply through 2022, suggesting the company will be constrained in its ability to boost sales targets for its latest games console.While reporting financial results in late April, the Japanese conglomerate said it had sold 7.8 million units of the console through March 31, and it is aiming to sell at least 14.8 million units in the current fiscal year. That would keep it on pace to match the trajectory of the popular PlayStation 4, which has sold in excess of 115.9 million units to date.In a briefing after those results, Sony told analysts it is challenging to keep up with strong demand. The PS5 has been difficult to find in stock since its release in November, in part because of shortages in components such as semiconductors, and the company hasn’t given an official estimate for when it expects supply to normalize.“I don’t think demand is calming down this year and even if we secure a lot more devices and produce many more units of the PlayStation 5 next year, our supply wouldn’t be able to catch up with demand,” Chief Financial Officer Hiroki Totoki said at the briefing, according to several people who attended and asked not to be named as it wasn’t public.A Sony spokesman declined to comment.Sony said it would buy back up to 200 billion yen ($1.8 billion) of its own shares after reporting profit for the March quarter that fell short of analyst estimates. It forecast that operating profit would slide about 4% in the current fiscal year, but analysts have been weighing whether the company could exceed the conservative outlook with the help of strong demand for the new console and games.Shares have dropped about 8% since the earnings report on April 28, after rising 75% over the previous year.Read More About Sony’s Plans For The Year AheadTotoki told analysts that Sony needs to ramp up production as soon as possible and make sure there are consoles on store shelves. Demand will remain high regardless of the Covid-19 situation, the CFO assured an analyst wary about Sony’s ability to fully capitalize on the stay-at-home entertainment surge triggered by lockdowns and emergency orders.“We have sold more than 100 million units of the PlayStation 4 and considering our market share and reputation, I can’t imagine demand dropping easily,” he said.Still, the company’s latest earnings report suggests that stay-at-home demand is leveling off. Sony said monthly active users on PlayStation Network fell to 109 million at the end of the January-March period from 114 million a quarter earlier and sales of full games also declined in the period from a year earlier.Rival Nintendo Co. warned last week that component shortages could affect production. It’s officially targeting sales of 25.5 million consoles in the year ending March 2022, down slightly from the previous year. But internally, Nintendo’s management is said to be shooting for production of between 28 and 29 million consoles., Bloomberg News has reported.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Ogletree Deakins and KPMG Law in Germany1 are forming a global alliance to provide businesses with global workforce solutions. This alliance will be instrumental in expanding immigration and employment law reach for both organizations and will enable KPMG firms outside of the US2 to bring the US capability and services of Ogletree Deakins to their clients around the world.
PALM BEACH, Fla., May 10, 2021 (GLOBE NEWSWIRE) -- Drug and alcohol treatment centers in Florida have a new wave of marketing by way of The Recover. The National addiction and mental health news publication is ramping up their efforts in Florida. The most recent data from the CDC’s National Vital Statistics System shows statistics from September 2019 through August 2020. During that period, there were 88,295 predicted deaths, a record high that is almost 19,000 more deaths (27%) than the prior 12-month period. Overdose rates for the state of Florida are not the highest in the country but have seen an estimated 42% increase according to the CDC. The Recover understands the urgency for people to find treatment options for those struggling from substance abuse, and partner with centers that accept veterans, rehabs for couples, and even pet friendly rehabs in Florida. In some Florida communities the Sheriff’s office are working to make a positive and lasting impression on young people and help them return from the streets to their communities. To combat drug abuse, local law enforcement agencies continue to rely on community health partners, such as the Florida Department of Health and the Department of Mental Health. They have partnered with health authorities that can provide help on a range of issues, including mental health, substance abuse, addiction, mental illness and drug use. The agency is working with a mental health initiative called Matter, which focuses primarily on youth suicide prevention, as well as the Florida Department of Mental Health and the state Health Department. The Institute conducts programs to inform policy and improve practice, as well as research and education on drug abuse and mental health issues. NIDA is a member of the National Institutes of Health (NIH) National Institute on Drug Abuse and is supported by the U.S. Centers for Disease Control and Prevention (CDC) and the Justice Department. Those who work as first responders know that recent overdoses are largely attributed to cocaine, prescription opioids and heroin and now fentanyl. Since COVID-19 first started upending day-to-day life for Americans in March 2020, public health officials have been sounding the alarm about a potential surge in drug overdoses. States like Florida, Georgia, Tennessee, and South Carolina could access significant federal financing in their push to help an ever-growing number of people in need. These four states all experienced overdose death increases above 30 percent during the first eight months of 2020. The Recover’s directory offers accredited drug rehab centers in Florida to treat a wide range of drug use problems, and many even offer luxurious rehab facilities. While some rehab centers can treat specific addiction problems, this is much less common in Florida. Most rehabilitation centers and psychiatric centers in Florida treat all forms of addiction, including drug and alcohol addiction. The Recover works with centers that provide treatment of mental illness such as depression, anxiety, bipolar disorder, and post-traumatic stress disorder. If someone is suffering from a co-occurring mental condition, there are treatment facilities in Florida that has help. The state of Florida offers a variety of treatment options for PTSD and other psychiatric disorders, from cognitive behavioral therapy (CBT) to psychotherapy. Patients can choose from a variety of evidence-based addiction therapies that meet their personal needs and goals. The Recover offers a drug rehab directory that is an ideal place to connect with Florida addiction treatment centers, as well as access to treatment for mental illnesses. To find substance abuse providers for a list of drug rehabs in Florida, use the addiction treatment centers page offered on their website. Although there are many substances that can lead to an overdose, according to the Florida Department of Health, you should be extra careful with certain medications. In response, additional precautions have been taken to ensure patient safety and the COVID-19 protocol is in place to provide you with the treatment you need. No one can forget that it needs to be treated when obstacles such as pandemics get in the way. [Sources: 0] If anyone would like to learn more about how to work together to reduce drug deaths in Florida by 2021, please contact The Recover. Author: William LeonardOrganization: The RecoverAddress: Orange County, CA 92648, USAPhone: (888) 510-3898Website: https://therecover.com/ Contact:Kevin Leonard1 714 email@example.com
Controversial Victorian Liberal MP Bernie Finn is under fire for posting a meme about a Chinese rocket falling on the national broadcaster or his political rivals.Mr Finn asked his Twitter followers: "Where should the Chinese rocket land.
Revenues expected to reach a record NIS 33 million (over CAD$12 million) Revenue growth of 8 times YoY and increased more than 22% sequentially Continued increase in operating profit, EBITDA and net profit Revenue growth expected to continue in Q2 and throughout 2021 CAD $68 million raised by successful completion of the SPAC merger InterCure continues to execute its profitable growth and global expansion strategy, and expects to list on the Nasdaq by the end of Q2 HERZLIYA, Israel, May 09, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (TSX: INCR:U, TASE: INCR)(dba Canndoc)(the “Company”) today announced preliminary financial results for the first quarter of 2021. Preliminary First Quarter 2021 Highlights Record revenue expected to be an estimated NIS 33 million, 8 times greater than Q1 2020 and an increase of more than 22% compared to Q4 2020;Continued increase in operating profit, EBITDA and net profit;Continued market share growth due to solid demand for Canndoc's branded products and the expansion of ‘GIVOL’ Pharmacy chain;Revenue growth expected to continue in Q2 and throughout 2021;Successful launch of CANNDOC Cali™ GMP premium product family, fully cultivated and manufactured in Canndoc's southern facility;LOI signed for the acquisition of Israeli medical cannabis LP 'Better';Californian cannabis brand Cookies™ to expand the brand to Europe through InterCure partnership. Preliminary First Quarter 2021 Results First quarter estimated revenue of NIS 33 million reflects an increase of 8 times compared to revenue of NIS 4 million in the prior year period. First quarter revenue reflects an increase of more than 22% sequentially compared to fourth quarter 2020 revenue of NIS 27 million. Revenue growth supported by solid demand for Canndoc's branded products, strategic and exclusive partnerships and the expansion of its distribution and dispensary footprint - ‘GIVOL’ pharmacy chain. Continued increase in operating profit, EBITDA and net profit reflects InterCure’s effective cost structure and operational excellence. Revenue growth expected to continue in the second quarter and throughout 2021. In addition, strategic agreements with industry’s leading brands including Aphria, Tilray, Organigram, Charlotte’s Web and recently Cookies establish and positions InterCure’s leadership and brand equity in international target markets, including Europe. CAD $68 million raised by successful completion of the SPAC merger with Subversive Acquisition LP and the LOI signed for the acquisition of Israeli medical cannabis LP 'Better' positions the company to further lead market consolidation as the fastest-growing, profitable cannabis company outside of North America. On April 20, 2021, InterCure applied to list on the Nasdaq and expects to begin trading by the end of Q2 2021. About InterCure (dba Canndoc) InterCure (dba Canndoc) (TSX:INCR.U, TASE:INCR) is the leading, fastest growing and the most profitable Israeli cannabis company. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to be the most profitable cannabis company globally outside of North America. InterCure is listed on the Toronto Stock Exchange under the symbol INCR.U and trades on the Tel Aviv Stock Exchange under the symbol INCR.TA. Listing of InterCure’s Shares on NASDAQ Expected in Q2 2021 and Will Trade Under the Symbol “INCR.” For more information, visit: http://www.intercure.co. Caution Regarding Financial Estimates The financial estimates set forth above are based on an initial review of the Company’s operations for the quarter ended March 31, 2021 and are subject to change. The Company’s independent registered public accounting firm, Somekh Chaikin (member firm of KPMG International), has not audited, reviewed or performed any procedures with respect to the accompanying financial estimates and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto. They should not be viewed as a substitute for audited financial statements prepared in accordance with generally accepted accounting principles and are not necessarily indicative of the Company’s results for any future period. Forward-Looking Statements This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects InterCure’s current expectations regarding future events. The words “will”, “expects”, “intends” and similar expressions are often intended to identify forward-looking information, although not all forward-looking information contains these identifying words. Specific forward-looking information contained in this press release includes, but is not limited to: the Company’s Q1 2021 revenue, the success of its global expansion plans, the expected annualized revenue for 2021, its continued growth, the expected operations, financial results business strategy, competitive strengths, goals and expansion and growth plans, expansion strategy to major markets worldwide and the expected listing of the Company’s shares on the NASDAQ. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond InterCure’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to: changes in general economic, business and political conditions, changes in applicable laws, the Canadian regulatory landscapes and enforcement related to cannabis, changes in public opinion and perception of the cannabis industry, reliance on the expertise and judgment of senior management, as well as the factors discussed under the heading “Risk Factors” in Subversive Acquisition LP’s final long form prospectus dated March 15, 2021, which is available on SEDAR at www.sedar.com. InterCure undertakes no obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. Contact: InterCure Ltd.Amos Cohen, Chief Financial Officeramos@canndoc-pharma.com
A man who found a bluebottle on a beach filmed himself licking the sea creature. Source: TikTok/@Alexa_reed2
Indian drugmaker Cipla Ltd said on Monday it had entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients. The agreement comes at a time when India is struggling with a catastrophic second wave of the pandemic, leading to an acute shortage of coronavirus medicines such as remdesivir and tocilizumab. Baricitinib has been given restricted emergency use approval by India's drug regulator for use in combination with remdesivir for the treatment of hospitalised COVID-19 adult patients requiring supplemental oxygen, Cipla said in a filing to stock exchanges.
The Canadian star's bad luck has continued with yet another tennis-related disappointment. Find out what happened.
While Japan's biggest automakers report what analysts expect to be depressed earnings this week, investors looking for trading cues will be tuned into any assessment of the future impact of a global chip shortage that has forced a shake-up in production. Automakers worldwide have had to adjust or suspend production in the past few months as factors including a surge in demand for electronic devices plus U.S. sanctions against Chinese technology firms led to a dearth of semiconductors. Blackouts in Texas where a number of chipmakers have factories and a fire at Renesas Electronics Corp's chip plant in Japan have exacerbated the supply crunch.